Sumary of Non-vitamin K antagonist oral anticoagulants beneficial for patients with AF, cancer:
- July 22, 2021 2 min read Source/Disclosures Published by: Disclosures: Chan reports no relevant financial disclosures.
- Back to Healio In patients with atrial fibrillation and cancer, non-vitamin K antagonist oral anticoagulants outperformed warfarin in thrombotic and bleeding endpoints, according to findings published in Stroke.
- 120.033470. The nationwide, retrospective, population-based cohort study assessed the Taiwan National Health Insurance Research Database from June 2012 to December 2017. Researchers identified 6,274 patients (mean age, 77 years;
- According to the researchers, the results of this study are important in clinical practice because this patient population is underrepresented in clinical trials, especially if presenting with active cancer.